News
Govt of Tamil Nadu in association with C-CAMP hosts Roundtable on Health: Our Bureau, Bengaluru Thursday, May 29, 2025, 17:30 ...
Lilly, Apollo Clinic & Apollo HealthCo partner to drive nationwide awareness on obesity and type 2 diabetes: Our Bureau, Bengaluru Thursday, May 29, 2025, 17:15 Hrs [IST] Eli Lill ...
Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...
Our Bureau, New Delhi Thursday, May 29, 2025, 16:15 Hrs [IST] ...
BioIVT & Handok Biotech ink commercial agreement to advance innovation in South Korea: Westbury, New York Thursday, May 29, 2025, 17:00 Hrs [IST] BioIVT, a global research partner ...
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery: Abbott Park, Illinois Thursday, May 29, 2025, 16:00 Hrs [IST] ...
Alamar Biosciences enters strategic collaboration with SciLifeLab to advance translational proteomics and accelerate biomarker discovery: Fremont, California Thursday, May 29, 202 ...
Supriya Lifescience delivers record-breaking FY25 with 22% revenue growth: Our Bureau, Mumbai Thursday, May 29, 2025, 14:30 Hrs [IST] The unaudited financial statements for the qu ...
Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...
China NMPA grants Priority Review status to CARsgen’s satri-cel to treat Claudin18.2-positive advanced G/GEJA: Shanghai, China Thursday, May 29, 2025, 13:00 Hrs [IST] CARsgen Th ...
US FDA grants fast track designation to EDDC’s antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma: Singapore Thursday, May 29, 2025, 12:00 Hrs [IST] The E ...
Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand
Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results